ArticleNPJ breast cancer2023

Author Correction: Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial.

Maria Vittoria Dieci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.